ReviewTherapeutic advances in musculoskeletal disease2018

Investigational therapies targeting the granulocyte macrophage colony-stimulating factor receptor-α in rheumatoid arthritis: focus on mavrilimumab.

Andrew D Cook et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.